Exploratory Evaluation of the Fibrosis-4 index, Albumin-bilirubin score, and Neutrophil-lymphocyte ratio (FAN) Sepsis Score for Prognosis in Patients With Poor Performance Status and Sepsis Due to Obstruction by Urinary Calculi

探索性评估纤维化-4指数、白蛋白-胆红素评分和中性粒细胞-淋巴细胞比值(FAN)脓毒症评分在尿路结石梗阻合并脓毒症且一般状况较差的患者预后中的价值

阅读:1

Abstract

BACKGROUND/OBJECTIVES: This study aimed to exploratory evaluate the association between fibrosis-4 index, albumin-bilirubin score, and neutrophil-lymphocyte ratio (FAN) sepsis (FANs) score, a sepsis score derived from fibrosis-4 index, albumin-bilirubin score, and neutrophil-lymphocyte ratio, and the prognosis of patients with poor performance status (PS) and sepsis associated with urinary tract stone obstruction. METHODS: We identified 56 patients with PS of 3 or 4 who were admitted to Kishiwada Tokushukai Hospital between April 2019 and March 2025 for septic shock due to obstructive pyelonephritis caused by a urinary tract stone. Patient information was collected retrospectively, and the association between prognosis and FANs score was evaluated. RESULTS: Patient characteristics were evaluated separately for each score group. Although differences were observed in the use of vasopressors, mean arterial pressure, procalcitonin, platelet counts, C-reactive protein, serum creatinine, and sequential organ failure assessment (SOFA) scores (p=0.04, p=0.01, p<0.01, p<0.01, p=0.01, p<0.01, and p<0.01, respectively), there were no other significant differences between the two groups. An increase in the FANs score was associated with increased mortality (p<0.01). Receiver operating characteristic (ROC) curve analysis showed that the FANs score had predictive ability equivalent to the SOFA score for in-hospital, one-year, and overall mortality. CONCLUSIONS: The FANs score may be associated with the prognosis of patients with poor PS and sepsis due to urinary tract stones.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。